Prior to joining MTS Health Partners as an Associate in 2025, Dr. Parinaz Emami was a Strategy Consultant at IQVIA, where she advised life science companies on corporate and portfolio strategies. Before her role at IQVIA, Dr. Emami worked at Merck, where she contributed to the development of both early- and late-stage biological drugs. She earned her PhD in Chemical Engineering from Pennsylvania State University, where her research was a collaborative project with Pfizer focused on vaccine development.